ModifiedBlue Cross Blue Shield - TexasPolicy CPCPLABO2O

Cardiovascular Disease Risk Assessment

Defines reimbursement criteria for laboratory tests used in cardiovascular disease (CVD) risk assessment and management for BCBSTX members, specifying reimbursable tests, non-reimbursable tests, and testing frequencies; applies to providers submitting claims and references plan-specific coverage variations.

Policy Summary

PayerBlue Cross Blue Shield - Texas

PolicyCardiovascular Disease Risk Assessment

Policy CodePolicy CPCPLABO2O

Change TypeFrequency update and code list modification

Effective DateMay 15, 2025

Next Review DateN/A

Key ActionSubmit claims using accurate documentation and valid HIPAA code sets; note updated reimbursable intervals and added/removed codes when billing.

SourceLink

POLICY UPDATE CHANGES

Reimbursement Information revised 1.a.i to read every 4 years for individuals ages 18 to 79 years.

Added "annually" to 1.d.

Added code 84512 and 0541U.

Removed code 0423T.

every 4 yearsrecommended interval (18-79)

annualhigh-risk frequency

2codes added

1codes removed

Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.

not reimbursablepanels excluded

Coverage Criteria for CVD Risk Assessment Testing

Testing frequency update

Operational updates to reimbursement frequency:

Revised routine screening interval for lipid panel (Reimbursement Information 1.a.i): every 4 years for individuals ages 18 to 79 years

Effective 05/15/2025

Added explicit annual timing for item 1.d: annually for individuals on long-term drug therapy when no medication changes have occurred

Clarifies frequency for stable long-term therapy

Code list changes

Updates to the list of reimbursable billing codes:

ALL of the following

84512
0541U

ALL of the following

0423T

Coding and Frequency Highlights

Example procedure codes listed (not exhaustive; inclusion does not guarantee coverage)CPT

80061	Lipid panel
81599	Unlisted pathology procedure (example included in code list)
82465	82465

Updated test codesCPT | HCPCS

84512	84512
0541U	0541U
0423T	0423T

inv-06: Lipid panel screening interval (ages 18-79) — Every 4 years

Lipid panel screening interval (ages 18-79)Every 4 years (Reimbursement Information 1.a.i)

PopulationIndividuals ages 18 to 79 years

ContextApplies to simple lipid panel screening to assess CVD risk

inv-07: frequency_interval_18_79 — every 4 years (duplicate/operational emphasis)

Frequency (operational)Every 4 years for individuals ages 18–79 (policy revision to Reimbursement Information 1.a.i)

Effective dateRevision documented in Policy Update History (effective 05/15/2025)

Provider Documentation, Billing, and Action Items

Documentation Required

Documentation and Coding Responsibility

Providers must submit accurate documentation of services performed and bill using valid HIPAA code sets. Claims are subject to review and may be adjudicated according to member plan documents and provider contracts. Upon request, providers should furnish additional documentation to support medical necessity and coding. Use industry-standard coding guidelines (e.g., CPT, HCPCS, ICD-10-CM/PCS, NDC, DRG, CMS NCCI edits).

Providers are responsible for accurate claim submission and supporting documentation.
Claims may be reviewed against benefit coverage, provider contract, medical policies, clinical payment and coding policies, and coding software logic.
Provide additional documentation upon request to validate services billed.

Billing Rule

Code List Update

Definitions and Supporting References

inv-11: simple lipid panel — definition/reference

DefinitionA simple lipid panel is generally composed of total cholesterol, LDL cholesterol, HDL cholesterol, and triglycerides.

Additional outputsCertain calculated ratios (e.g., total/HDL cholesterol) may also be reported as part of a simple lipid panel.

ExclusionsApolipoproteins, lipid particle number/size, and lipoprotein(a) are not considered components of a simple lipid panel.

inv-12: PCEs — Pooled Cohort Equations (2013 ACC/AHA) used to calculate 10-year CVD risk and determine some testing eligibility

AcronymPCEs = Pooled Cohort Equations (2013 ACC/AHA)

UseUsed to calculate 10-year risk of CVD events and to define individuals at increased risk for whom annual testing may be indicated.

Policy Summary

PayerBlue Cross Blue Shield - Texas

PolicyCardiovascular Disease Risk Assessment

Policy CodePolicy CPCPLABO2O

Change TypeFrequency update and code list modification

Effective DateMay 15, 2025

Next Review DateN/A

Key ActionSubmit claims using accurate documentation and valid HIPAA code sets; note updated reimbursable intervals and added/removed codes when billing.

SourceLink

On This Page

Reference noteSee Reimbursement Information for screening and monitoring intervals

inv-08: frequency_item_1d — annually (frequency clarification for item 1.d)

Frequency for item 1.dAnnually (added to Reimbursement Information item 1.d)

Applies toIndividuals on long-term drug therapy when no medication changes have occurred

Documented changePolicy Update History records addition of "annually" to 1.d

Reimbursement information and the policy code list were updated effective 05/15/2025. Added CPT/HCPCS codes: 84512 and 0541U. Removed code: 0423T. Ensure billing systems and claim submissions reflect these code list changes on or after the effective date.

Added codes: 84512, 0541U
Removed code: 0423T
Effective date of change: 2025-05-15

Guidance notePCEs are a population risk estimator; clinicians may individualize risk with additional risk-enhancing factors.

inv-13: References — guideline and literature sources cited to support coverage and reimbursement decisions

Primary guideline sources2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk and related AHA/ACC cholesterol management guidance (referenced in NOTE 2 and References).

Other guideline and literature examplesAHA/ACC, Endocrine Society/AACE guidelines, clinical studies and journal articles cited in the References section.

Policy update noteReferences were revised as part of the Policy Update History (see 02/05/2025 update).